https://www.businessline.global/data-at-eahad-2021-highlight-value-of-takedas-leading-hematology-portfolio-in-clinical-settings-and-commitment-to-patient-focused-advancements/press-release/
Data at EAHAD 2021 Highlight Value of Takeda's Leading Hematology Portfolio in Clinical Settings and Commitment to Patient-Focused Advancements